Skip to main content
Figure 8 | BMC Pharmacology

Figure 8

From: Protective efficacy of natansnin, a dibenzoyl glycoside from Salvinia natans against CCl4 induced oxidative stress and cellular degeneration in rat liver

Figure 8

Effect of CCl 4 with or without prior administration of natansnin on PARP cleavage. Whole cell protein extracted from control, CCl4 and natansnin (10 mg/kg, 20 mg/kg body weight) treated rats and separated on 12% SDS gels and transferred on to nitrocellulose membranes. Immunoblot was detected with PARP specific primary antibody. The expression levels of β-actin were used as loading controls. Densitometric analysis showing the protein levels of PARP were increased in CCl4 group while treatment with natansnin significantly decreased the protein levels. Data are represented as mean ± standard deviation from three independent experiments (*p < 0.05 indicate significant difference relative to the CCl4 treated rats).

Back to article page